Nordic Society for Pediatric Hematology and Oncology   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Stockholm Sweden (2013)

Organization Overview

First Clinical Trial
2013
NCT00192673
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now